Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Demographic determinants of hepatitis C virus seroprevalence among blood donors.

Murphy EL, Bryzman S, Williams AE, Co-Chien H, Schreiber GB, Ownby HE, Gilcher RO, Kleinman SH, Matijas L, Thomson RA, Nemo GJ.

JAMA. 1996 Apr 3;275(13):995-1000.

PMID:
8596257
2.

Demographic determinants of syphilis seroprevalence among U.S. blood donors, 2011-2012.

Kane MA, Bloch EM, Bruhn R, Kaidarova Z, Murphy EL.

BMC Infect Dis. 2015 Feb 15;15:63. doi: 10.1186/s12879-015-0805-3.

3.

Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors.

Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R.

Am J Trop Med Hyg. 1993 Oct;49(4):440-7.

PMID:
7692754
4.

The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations.

Wang J, Liu J, Huang Y, Wright DJ, Li J, Zhou Z, He W, Yang T, Yao F, Zhu X, Wen G, Bi X, Tiemuer MH, Wen X, Huang M, Cao R, Yun Z, Lü Y, Ma H, Guo N, Yu Q, Ness P, Shan H; NHLBI Retrovirus Epidemiology Donor Study-II International Component..

Transfusion. 2013 Oct;53(10 Pt 2):2489-97. doi: 10.1111/trf.12297.

PMID:
23781978
5.

Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)

Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, Nass CC, Williams AE.

JAMA. 2000 Jul 12;284(2):229-35.

PMID:
10889598
6.

Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.

Chang YB, Kaidarova Z, Hindes D, Bravo M, Kiely N, Kamel H, Dubay D, Hoose B, Murphy EL.

J Infect Dis. 2014 Feb 15;209(4):523-31. doi: 10.1093/infdis/jit497.

7.
8.

High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.

Esteban JI, López-Talavera JC, Genescà J, Madoz P, Viladomiu L, Muñiz E, Martin-Vega C, Rosell M, Allende H, Vidal X, et al.

Ann Intern Med. 1991 Sep 15;115(6):443-9.

PMID:
1651674
9.

Effect of a national disaster on blood supply and safety: the September 11 experience.

Glynn SA, Busch MP, Schreiber GB, Murphy EL, Wright DJ, Tu Y, Kleinman SH; NHLBI REDS Study Group..

JAMA. 2003 May 7;289(17):2246-53.

PMID:
12734136
10.

Hepatitis C virus infection in former commercial plasma/blood donors in rural Shanxi Province, China: the China Integrated Programs for Research on AIDS.

Qian HZ, Yang Z, Shi X, Gao J, Xu C, Wang L, Zhou K, Cui Y, Zheng X, Wu Z, Lu F, Lai S, Vermund SH, Shao Y, Wang N.

J Infect Dis. 2005 Nov 15;192(10):1694-700.

11.

Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.

Busch MP, Glynn SA, Stramer SL, Orland J, Murphy EL, Wright DJ, Kleinman S; NHLBI Retrovirus Epidemiology Donor Study (REDS) Group..

Transfusion. 2006 Mar;46(3):469-75.

PMID:
16533292
12.

Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)

Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, Nass CC, Ownby HE, Schreiber GB, Kong F, Neal KR, Nemo GJ.

Hepatology. 2000 Mar;31(3):756-62.

PMID:
10706569
13.

Transfusion-transmissible infections among blood donors in Kathmandu, Nepal.

Shrestha AC, Ghimire P, Tiwari BR, Rajkarnikar M.

J Infect Dev Ctries. 2009 Dec 15;3(10):794-7.

14.
15.
16.

Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index.

Murphy EL, Fang J, Tu Y, Cable R, Hillyer CD, Sacher R, Triulzi D, Gottschall JL, Busch MP; Retrovirus Epidemiology Donor Study..

J Infect Dis. 2010 Aug 15;202(4):576-84. doi: 10.1086/654882.

17.

Epidemiological and clinical aspects of hepatitis C virus infection in the Russian Republic of Daghestan.

Abdourakhmanov DT, Hasaev AS, Castro FJ, Guardia J.

Eur J Epidemiol. 1998 Sep;14(6):549-53.

PMID:
9794121
18.

Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009.

Nagalo MB, Sanou M, Bisseye C, Kaboré MI, Nebie YK, Kienou K, Kiba A, Dahourou H, Ouattara S, Zongo JD, Simporé J.

Blood Transfus. 2011 Oct;9(4):419-24. doi: 10.2450/2011.0112-10.

19.

Seroprevalence of HIV and hepatitis C co-infection among blood donors in Kathmandu Valley, Nepal.

Karki S, Ghimire P, Tiwari BR, Shrestha AC, Gautam A, Rajkarnikar M.

Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):66-70.

PMID:
19323036
20.

Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.

Baha W, Foullous A, Dersi N, They-they TP, El alaoui K, Nourichafi N, Oukkache B, Lazar F, Benjelloun S, Ennaji MM, Elmalki A, Mifdal H, Bennani A.

BMC Public Health. 2013 Jan 18;13:50. doi: 10.1186/1471-2458-13-50.

Items per page

Supplemental Content

Support Center